Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Klotho Neurosciences, Inc. (KLTO) had Return on Equity of -29.17% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-2.90M |
|
-- |
|
-- |
|
$1.85M |
|
$-1.85M |
|
$-1.04M |
|
$-2.90M |
|
$-2.90M |
|
$-2.90M |
|
$-2.90M |
|
$-2.90M |
|
$-2.90M |
|
$-1.85M |
|
$-1.85M |
|
59.42M |
|
59.42M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$7.77M |
|
-- |
|
$2.30M |
|
$10.07M |
|
$0.09M |
|
-- |
|
$0.05M |
|
$0.15M |
|
$9.93M |
|
$7.63M |
|
$9.93M |
|
70.33M |
|
| Cash Flow Statement Financials | |
$-4.61M |
|
-- |
|
$11.89M |
|
$0.06M |
|
$7.35M |
|
$7.28M |
|
$1.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
83.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-29.17% |
-37.96% |
|
-28.75% |
|
-29.17% |
|
$0.14 |
|
$-0.08 |
|
$-0.08 |
|